Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

news.google.com

enzalutamide resgistry - Google News

Get the latest updates from enzalutamide resgistry - Google News directly as they happen.

Follow now < 10 followers

Latest posts

Last updated about 2 years ago

LYNPARZA® (olaparib) reduced risk of death by 32% in the adjuvant treatment of patients with germline BRC - Benzinga

about 2 years ago

LYNPARZA® (olaparib) reduced risk of death by 32% in the adjuvant treatment...

LYNPARZA® (olaparib) Reduced Risk of Death by 32% in Patients With Germline BRCA-Mutated, HER2-Negative H - Benzinga

about 2 years ago

LYNPARZA® (olaparib) Reduced Risk of Death by 32% in Patients With Germline...

Pfizer Completes Acquisition of Arena Pharmaceuticals - InvestingNews.com

about 2 years ago

Pfizer Completes Acquisition of Arena Pharmaceuticals  InvestingNews.com

Generic Oncology Drugs Market estimated to account for revenue of US$ 34.8 Bn by the end of 2028 - GlobeNewswire

about 2 years ago

Generic Oncology Drugs Market estimated to account for revenue of US$ 34.8...

Generic Oncology Drugs Market estimated to account for revenue of US$ 34.8 Bn by the end of 2028 - GlobeNewswire

about 2 years ago

Generic Oncology Drugs Market estimated to account for revenue of US$ 34.8...

Prostate Cancer Diagnoses Plunged During First COVID-19 Lockdown in England - Renal and Urology News

about 2 years ago

Prostate Cancer Diagnoses Plunged During First COVID-19 Lockdown in England  Renal and...

Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Share, Trend Industry Development Scenario and Forecast 2021-2030 - Taiwan News

about 2 years ago

Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Share, Trend Industry Development Scenario...

Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials - Cureus

about 2 years ago

Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic...

Argenx straddles the line between drug promotion and awareness in latest unbranded DTC TV ad - FiercePharma

about 2 years ago

Argenx straddles the line between drug promotion and awareness in latest unbranded...

AstraZeneca's Alexion wants to make sure rare is still seen and heard - FiercePharma

about 2 years ago

AstraZeneca's Alexion wants to make sure rare is still seen and heard...

Heron's opioid alternative Zynrelef, slated for blockbuster status, hits a rough Q4 as Jefferies seek 'launch clarity' - FiercePharma

about 2 years ago

Heron's opioid alternative Zynrelef, slated for blockbuster status, hits a rough Q4...